1 recruiting, 1 terminated, 1 unknown. 3 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Recruiting 1, Terminated 1, Unknown 1 |
| Phase 2 | 2 | Terminated 1, Unknown 1 |
Follow Zeaxanthins: new trials by email Literature Review of Zeaxanthins trials Research Report on Zeaxanthins
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Determine Safety & Recommended Phase 2 Dosing of Zeaxanthin Alone or in Combination w/Pembrolizumab in Patients With Metastatic Cancer Zeaxanthin, Zeaxanthin Plus Pembrolizumab - Cancer Metastatic, Metastatic Solid Tumor | Phase 1 | Recruiting | Valley Health System | 72 | 2022-04-17 | 2026-06-05 |
| Macular Pigment and Visual Performance in Glaucoma Patients Lutein, zeaxanthin and mesozeaxanthin, Placebo - Glaucoma | Phase 1 / Phase 2 | Terminated | Felipe Medeiros, MD | 8 | 2019-08-21 | 2023-01-03 |
| Effects of Lutein and Zeaxanthin Supplementation on Age-related Macular Degeneration lutein, Lutein, placebo - Age-related Macular Degeneration | Phase 1 / Phase 2 | Unknown | Peking University | 120 | 2009-09-01 | 2012-03-16 |
Glaucoma (1) · Macular Degeneration (1) · Neoplasm Metastasis (1)
Felipe Medeiros, MD (1) · Peking University (1) · Valley Health System (1)
United States (2) · China (1)
Felipe A Medeiros, MD, PhD (1) · Philip Friedlander, MD (1)